Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
CELULARITY
Show more
Class 1: bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research
Class 5: Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimer…
Class 1 – ChemicalsClass 5 – Pharmaceuticals & supplements
Status timeline
- 18 Jun 2020Application filedNew Application Entered
- 5 Aug 2020Assigned to an examining attorneyAssigned To Examiner
- 7 Aug 2020Office action issuedNon-Final Action Written
- 15 Sep 2020Response to office action filedTeas Response To Office Action Received
- 9 Oct 2020Approved for publicationApproved For Pub - Principal Register
- 17 Nov 2020Published for oppositionPublished For Opposition
- 2 Feb 2021Registered on the Principal RegisterRegistered-Principal Register
- 12 Jan 2022Ownership assignment recordedAutomatic Update Of Assignment Of Ownership
- 7 Jan 2026Ownership assignment recordedAutomatic Update Of Assignment Of Ownership
All 20 events
| 2026-02-02 | Rem1 |
| 2026-01-07 | Automatic Update Of Assignment Of Ownership |
| 2022-01-12 | Automatic Update Of Assignment Of Ownership |
| 2021-02-02 | Registered-Principal Register |
| 2020-11-17 | Published For Opposition |
| 2020-11-17 | Official Gazette Publication Confirmation E-Mailed |
| 2020-10-28 | Notification Of Notice Of Publication E-Mailed |
| 2020-10-09 | Approved For Pub - Principal Register |
| 2020-10-08 | Teas Change Of Owner Address Received |
| 2020-10-08 | Teas Change Of Correspondence Received |
| 2020-10-08 | Applicant/Correspondence Changes (Non-Responsive) Entered |
| 2020-09-16 | Teas/Email Correspondence Entered |
| 2020-09-15 | Teas Response To Office Action Received |
| 2020-09-15 | Correspondence Received In Law Office |
| 2020-08-07 | Non-Final Action Written |
| 2020-08-07 | Non-Final Action E-Mailed |
| 2020-08-07 | Notification Of Non-Final Action E-Mailed |
| 2020-08-05 | Assigned To Examiner |
| 2020-07-14 | New Application Office Supplied Data Entered |
| 2020-06-18 | New Application Entered |
Goods & services by class
Class 1 Chemicals
bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research
First use anywhere 6 Dec 2018 · First use in commerce 6 Dec 2018
Class 5 Pharmaceuticals & supplements
Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimer…
First use anywhere 6 Dec 2018 · First use in commerce 6 Dec 2018
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 3 Feb 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.